|
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. J Clin Oncol 1998; 16:78.
|
www.uptodate.com/patients/content/topic.do?topicKey=~8w...
www.uptodate.com/patients/content/topic.do?topicKey=~8wvcVjO0H2MHBw
|
|
|
|
We analyzed the outcome of patients aged more than 60 included in a multicenter trial in newly diagnosed acute promyelocytic leukemia (APL93 trial), which tested the role of early addition of chemotherapy to all trans retinoic acid (ATRA) and of maintenance with ATRA and/or low-dose chemotherapy.
|
www.nature.com/leu/journal/v19/n2/abs/2403597a.html
|
|
|
Background: The incidence and prognostic value of additional chromosome abnormalities (ACA) in acute promyelocytic leukemia (APL) is still a controversial matter.
|
www.haematologica.org/cgi/content/abstract/haematol.200...
www.haematologica.org/cgi/content/abstract/haematol.2009.013243v1
|
|
Automatic download; [Begin manual download] ... Downloading the PDF version of:; Haematologica Montesinos et al. 94 (9): 1242. (186K) ... This file is in Adobe Acrobat (PDF) format. If you have not installed and configured the Adobe Acrobat Reader on your system, see Help with Printing for instructions.
|
www.haematologica.org/cgi/reprint/94/9/1242
|
|
|
CD56 Expression Is an Indicator of Poor Clinical Outcome in Patients With Acute Promyelocytic Leukemia Treated With Simultaneous All-Trans-Retinoic Acid and Chemotherapy; J. Clin. Oncol., March 13, 2000; 18(6): 1295 - 1300. [Abstract] [Full Text] [PDF];
|
jco.ascopubs.org/cgi/content/abstract/16/1/78
|
|
|
Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide ... Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic Leukemia; Ann Intern Med, November 6, 2001; 135(9): 842 - 843. [Full Text] [PDF];
|
bloodjournal.hematologylibrary.org/cgi/content/short/98...
bloodjournal.hematologylibrary.org/cgi/content/short/98/2/266
|
|
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
|
www.ncbi.nlm.nih.gov/pubmed/18945964
|
|
PURPOSE: To retrospectively determine the outcome of acute promyelocytic leukemia (APL) patients who underwent autologous or allogeneic stem-cell transplantation (SCT) during second complete remission.
|
www.medscape.com/medline/abstract/15534358?queryText=ac...
www.medscape.com/medline/abstract/15534358?queryText=acute%20promyelocytic%20leukemia
|
|
Impact of FLT3 mutations and secondary cytogenetic changes on the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with a single agent arsenic trioxide regimen; Haematologica, July 1, 2007;
|
www.jco.org/cgi/content/abstract/15/5/1786
|
|
